These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11481818)

  • 1. Pharmaceutical price controls at the state level.
    Kozma CM
    Manag Care Interface; 2001 Jul; 14(7):59-60. PubMed ID: 11481818
    [No Abstract]   [Full Text] [Related]  

  • 2. These doctor's mission: keeping drug costs down.
    Guglielmo WJ
    Med Econ; 2001 Apr; 78(8):108-10, 113-6. PubMed ID: 11386066
    [No Abstract]   [Full Text] [Related]  

  • 3. Northeast states pursue price controls to stop rise in prescription drug costs.
    Carlson B
    Manag Care; 2000 May; 9(5):12-3. PubMed ID: 11185259
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PhRMA challenges Maine's novel Rx law.
    Tieman J
    Mod Healthc; 2000 Aug; 30(34):12-3. PubMed ID: 11185156
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 8. Rx price controls: Maine gets a go-ahead.
    Guglielmo WJ
    Med Econ; 2001 Jul; 78(13):23, 27. PubMed ID: 11478173
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals: pharmacy benefit management regulations--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-9. PubMed ID: 16710927
    [No Abstract]   [Full Text] [Related]  

  • 10. If foreign drug prices go up, will U.S. prices come down?
    Med Health; 2003 Dec; 57(45):2-4. PubMed ID: 14723168
    [No Abstract]   [Full Text] [Related]  

  • 11. [Barmer reimbursement insurance pays pharmacists a fee for monitoring physicians. Pharmacists now control their prescriptions!].
    Schmidt K
    MMW Fortschr Med; 2004 May; 146(21):55-6. PubMed ID: 15373087
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals: pharmaceutical cost controls.
    Seay M; Lee LL
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-22. PubMed ID: 17357250
    [No Abstract]   [Full Text] [Related]  

  • 13. Increasing generic drug use in Medicare Part D: the role of government.
    Kohl H; Shrank WH
    J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887
    [No Abstract]   [Full Text] [Related]  

  • 14. Affordable prescription drugs--state and federal action.
    Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicaid program; prescription drugs. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Jul; 72(136):39141-245. PubMed ID: 17674494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling the cost of prescription drugs.
    White JR
    Health Prog; 1992 Mar; 73(2):12-4, 25. PubMed ID: 10116498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Family physicians resist high prescription risk].
    Schmidt K
    MMW Fortschr Med; 2003 May; 145(20):58. PubMed ID: 12822233
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare should bargain for lower drug prices, study says.
    Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
    [No Abstract]   [Full Text] [Related]  

  • 19. Affordable prescription drugs for NC consumers: the next challenge.
    Savage HH
    N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward a rational, value-based drug benefit for Medicare.
    Lopert R; Moon M
    Health Aff (Millwood); 2007; 26(6):1666-73. PubMed ID: 17978385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.